{
    "nctId": "NCT04292860",
    "briefTitle": "Reverse Axillary Mapping in Breast Radiation Treatment Planning",
    "officialTitle": "Reverse Axillary Mapping as a Lymphedema Prevention Strategy in Breast Radiation Treatment Planning",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, Lymphedema",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Delineation of the upper extremity lymphatics (UEL) during the radiation treatment planning process using axillary reverse mapping (ARM)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* De novo presentation of post-operative (lumpectomy or mastectomy) female breast cancer patients to receive radiation to the whole breast or chest wall and the regional nodes. Patients who have received a sentinel lymph node (SLN) biopsy or an axillary lymph node dissection (ALND) will be eligible.\n* Greater than or equal to 18 years of age (no upper age limit).\n* Informed consent obtained.\n\nExclusion Criteria:\n\n* Prisoners.\n* Patients with metastatic breast cancer.\n* Documented allergy to iodinated contrast\n* Prior breast or axillary surgeries or radiation.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}